ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
The development of countermeasures that aid in the prevention and propagation of SARS-CoV-2 infections is critical to manage the continuing crisis brought about by COVID-19. Here we present a proof-of-concept study on the use of cell-mimetic microparticles (Cytomimetics) for the interference and seq...
Main Authors: | Thomas A. Strong, Daniel Pelaez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Biotechnology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2215017X21000977 |
Similar Items
-
Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
by: Yixin Xie, et al.
Published: (2020-12-01) -
The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains
by: Rongrong Chen, et al.
Published: (2021-01-01) -
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
by: Sally Badawi, et al.
Published: (2021-01-01) -
Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021-02-01) -
ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives
by: Federica Saponaro, et al.
Published: (2020-09-01)